Is The Extract Of Cistanche Tubulosa Based On Indicators Or Only On The Place Of Origin?

The two most common questions when buying Cistanche tubulosa extract are: "Is the content sufficient?" and "Is it produced in Xinjiang/Alxa. Both of these questions are correct, but if the order is reversed, the conclusion often becomes biased.

Cistanche tubulosa extract

Correction: Cistanche tubulosa is not a type, and its extract is not a "one pot stew"

There are only two types of plants in the Cistanche genus that are legally used in the Chinese Pharmacopoeia: Cistanche deserticola (commonly known as "Soft Big Yun") and Cistanche tubulosa (commonly known as "Hard Big Yun" or "Jiang Yun"). Although the two belong to the same family and category, with similar efficacy, there are significant differences in their chemical composition spectrum, content ceiling, and application scenarios, and they should not be confused.

A key understanding is that the core active markers of Cistanche tubulosa are phenylethanoid glycosides (PhGs), among which echinacoside and verbascoside (also known as ergosterol glycosides) are the most critical. The pharmacopoeia sets completely different requirements for the "total lower limit" of the two sources - this is the first criterion for distinguishing between the two sources and determining the value of the extract.

Cistanche tubulosa, Cistanche deserticola

Extract "first look at the indicators, then look at the place of origin"; Many people have turned things around

A widely debunked logic is to first ask 'Is it produced in Xinjiang?' and then ask 'What is the content?'. For the extract of Cistanche tubulosa, the more secure sequence is exactly the opposite - first look at the indicators, then look at the place of origin. There are three reasons.

Firstly, indicators directly determine the 'quantity' of functional substances. Extracts are industrial raw materials used downstream in health products, tablet candies, cosmetics, or pharmaceutical intermediates. What really works is not the "where they come from" label, but the amount of echinacoside, verbascoside, and even total phenylethanolic acid in each gram of powder. The pharmacopoeia only specifies the lower limit of raw medicinal materials, while extract products have their own specifications and grades, and the content can vary several times.

Secondly, the origin is a "ceiling" rather than a "certificate of conformity". The desert shrub belt in Hotan and southern Xinjiang is indeed the authentic production area of Cistanche tubulosa. The conditions of Kunlun Mountain glacier meltwater irrigation, parasitic red willow roots, and large-scale planting have made the local raw material phenylethanolic glycoside base good and the supply stable. But 'correct origin' only means the possibility of producing high-content raw materials, and does not automatically mean 'this batch of extracts meets the standards'. Different harvesting periods, processing techniques, and extraction and purification batches in the same production area can lead to differences in indicators.

Cistanche tubulosa experiment

Thirdly, regulatory and application compliance should be jointly locked in with "source+indicators". Guanhua Cistanche is only used as a traditional Chinese medicine and cannot be directly used as a raw material for ordinary food; And desert Cistanche belongs to the medicinal and edible homology, which can be used for ordinary food. If the total glycosides from Guanhua are used to make solid beverages and other ordinary foods, even if the origin is authentic, it is still a wrong application direction. That is to say, the origin cannot answer compliance questions; only the boundary between the source and the use can be determined.

Therefore, the correct order for procurement and material selection is: first confirm that the base source is Cistanche tubulosa (with Latin name Cistanche tubulosa) → then check the indicators of pinealoside, verbascoside/total phenylethanol glycosides in each batch of testing reports → finally use "Xinjiang Southern Xinjiang Core Production Area+Standardized Planting+Light Avoidance Packaging" to confirm the additional points for the origin. Treating the origin as the first and only judgment is putting the cart before the horse.

Main Chemical Constituents of Cistanche tubulosa

Why "Highlight Cistanche tubulosa": It is the protagonist of the extract track

The extraction and feeding materials for market circulation mostly use Xinjiang Guanhua Cistanche tubulosa. The fundamental reason is that its phenylethanolic glycoside content is significantly higher than that of desert Cistanche tubulosa, resulting in higher raw material efficiency and total glycoside content for extracting high-quality products.

Phenylethanol glycoside is the main active component of Cistanche tubulosa

The research data intuitively illustrates this difference: before the flowering period of Xinjiang Guanhua Cistanche tubulosa, the content of echinacroside can reach 16.040 mg/g and verbascoside can reach 3.714 mg/g, both higher than the desert Cistanche tubulosa measured at the same time; And Li Jiawei et al. reported that the total amount of pineal and verbascoside in Cistanche tubulosa is about 2.26%, which is higher than the 0.73% in desert Cistanche tubulosa. Among them, the pineal glycoside in Cistanche tubulosa is almost six times that of desert. The overall composition and efficacy comparison of Tu Pengfei's team also pointed out that the glycosides of Guanhua phenylethanolic acid are more prominent and have advantages in kidney tonifying, nourishing essence, anti-aging, anti Alzheimer's disease, and liver protection.

At the same time, almost all of the Cistanche tubulosa is artificially grown on a large scale, with high yield and cost-effectiveness, making it the variety with the largest industrial raw material consumption; However, wild resources of desert Cistanche tubulosa are scarce and expensive, and due to its prominent polysaccharides and betaines, it focuses more on moisturizing the intestines, promoting bowel movements, and providing daily mild nourishment.

In short, when it comes to "extracting phenylethanolic glycosides", Guanhua is a more appropriate and mainstream choice; When it comes to "making ordinary food/mild moisturizing intestines", we should return to desert Cistanche tubulosa. Clarify the value of Guanhua Cistanche, not to belittle desert Cistanche, but to use the raw materials in the direction they are best at.

How to view indicators: Don't just focus on one "total glycoside"; focus on "dual core+specification"

The qualified extract of Cistanche tubulosa should be standardized based on the dual core indicators of echinacoside and verbascoside. The common specification grading (enterprise standard/product specification) in the market can refer to the following range. When purchasing, choose according to your own formula needs, rather than blindly chasing after high standards.

When looking at indicators, there are three points to pay attention to: firstly, methodology - echinacoside and verbascoside must be quantified by HPLC with a detection wavelength of 330 nm, and the report should provide clear values rather than vague "qualified". Secondly, proportion - Echinochlorin usually accounts for the majority. If verbascoside is abnormally high or the ratio of the two is severely imbalanced, it needs to be judged based on methodology. Thirdly, do not mix "total phenylethanolic acid glycosides ≥ a certain value" with "total amount of echinacoside+verbascoside". The former is a crude index of total glycosides, while the latter is a pharmacopoeial marker of dual monomers. The two complement each other rather than replace each other.

Should we look at the place of origin? It should be seen, but it's about 'verifiability'

Emphasizing 'looking at indicators first' does not mean that the origin is irrelevant. For Cistanche tubulosa, the true value of its origin lies in its traceability and stability: it should be specified to the "Xinjiang Uyghur Autonomous Region" and preferably accompanied by a description of the specific production area in southern Xinjiang (such as the Hotan area) and proof of raw material traceability; Simultaneously confirm the Latin scientific name and batch traceability of the raw material source.

cistanche extract powder

Click here to view Cistanche Tubulosa Extract Natural Supplement Powder

【Ask for more】 Email:cindy.xue@wecistanche.com / WhatsApp: 0086 18599088692 / WeChat: 18599088692

In addition, the harvesting period directly affects the content. Research suggests that the content of phenylethanoid glycosides in Cistanche tubulosa is relatively higher before the flowering period; And there is also a pattern in desert Cistanche that 'non-bolting (nutritional period) is better than bolting (after flowering)'. Therefore, if the origin information can be further reduced to the level of "harvesting period+no bolting/before flowering period", it will have more reference value for the stability of indicators.

Processing and storage will also 'eat up' the indicators. Phenylethanolic glycosides are sensitive to light, and light-resistant packaging (dark bottles/aluminum-plastic panels/aluminum foil bags) is a fundamental quality requirement; The extract should be sealed, kept cool and dry, and stored away from light and high temperatures. If the packaging of the product received is not light shielded, the testing report is missing, or only labeled as "Xinjiang Cistanche" without the source and content, the bonus points for the place of origin cannot be discussed.

Reference and Explanation

1) The threshold for pharmacopoeia content and the detection method for dual monomers (echinacoside/verbascoside) can be found in the relevant general rules of the Chinese Pharmacopoeia (HPLC-UV, detection wavelength 330 nm).

2) The "Extract Specification" in this article is an example of common product specifications in the market and is not a mandatory standard in pharmacopoeia; The finished product shall be subject to the manufacturer's COA (Certificate of Inspection) for each batch.

3) Application compliance reminder: Cistanche tubulosa is only used as a traditional Chinese medicine; When it comes to the development of ordinary food, compliant sources should be selected according to regulations, and professional opinions should be consulted.